Rappta Therapeutics
Rappta Therapeutics is a biotech company. It has 1 recorded funding round, most recently a Series A in October 2020.
Focused on a New Paradigm for Fighting Cancer
- Website
- rappta-therapeutics.com
- Last Round
- Series AOct 2020
- Rounds
- 1
Indexed holds 1 funding round and 4 investors for this company. The full record is or through the API.
About
Rappta Therapeutics is a lead-optimization stage biopharmaceutical company. We are working on a first-in-class series of anti-cancer molecules that reactivate a key tumor suppressor, protein phosphatase 2A (PP2A).
Summary
Its most recent funding was a Series A round in Oct 2020. Investors include Novartis Venture Fund, Novo Holdings A/S and Advent Life Sciences.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Oct 2020
Investors
Similar Companies
Altos Labs combines academic science and industry development to create medicines that restore ce...
BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/rappta-therapeutics"><img src="https://indexed.vc/api/badge/company/rappta-therapeutics" alt="Rappta Therapeutics on Indexed.vc" width="260" height="76" /></a>